Clinical Trial Update: ANti-Oxidant in Variant Angina (ANOVA) Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial ANti-Oxidant in Variant Angina (ANOVA) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Variant Angina

Drugs mentioned

• ANti-Oxidant in Variant Angina (ANOVA)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Variant Angina | Phase 4 | Status: TERMINATED